Back to Tudor Investment Corp. Tudor Investment Corp.

CLDX

Showing 7 of 13 quarters

Position history for Tudor Investment Corp.Tudor Investment Corp.'s holdings in Celldex Therapeutics, Inc.

No. Tudor Investment exited its CLDX (Celldex Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 35,393 shares worth $1.1M. Tudor Investment first reported CLDX in Q1 2023 and held it in 9 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$822,412

Total Shares Change

-32,545

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$37.21
0
2026-Q1
New
35,393
-
$1.1M0.0%$31.72
35
2025-Q4
Exited
0
-100.0%
$00.0%$27.16
0
2025-Q3
New
31,618
-
$817,9580.0%$25.87
34
2025-Q2
Exited
0
-100.0%
$00.0%$20.35
0
2025-Q1
Increased
35,141
+8.0%
$637,8090.0%$18.15
26
2024-Q4
New
32,545
-
$822,4120.0%$25.27
34

Other major holders of CLDX: FMR LLC, Wellington Management Group LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used